Heptares Therapeutics (United Kingdom)
At Nxera Pharma, our mission is to accelerate the development of life-changing medicines by investing in science and technology. Our world-leading and proprietary NxWave™ platform enables us to unlock the potential of GPCRs to rational structure-based drug design and develop life-changing medicines.
Basic Information
- Category: business
- Founded: 2007
- Headquarters: Welwyn Garden City
- Website: http://www.heptares.com/
Documented Facts
- Founded: 2007 (No linked source recorded for this statement.)
- Website: http://www.heptares.com/ (No linked source recorded for this statement.)
- Headquarters: Welwyn Garden City (No linked source recorded for this statement.)
- Country: United Kingdom (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Heptares Therapeutics (United Kingdom).
- Canonical profile: https://brandsource.ai/brands/heptares-therapeutics-united-kingdom
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/heptares-therapeutics-united-kingdom/json-ld
- Citation profile API: https://brandsource.ai/api/brands/heptares-therapeutics-united-kingdom/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (86/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
At Nxera Pharma, our mission is to accelerate the development of life-changing medicines by investing in science and technology. Our world-leading and proprietary NxWave™ platform enables us to unlock the potential of GPCRs to rational structure-based drug design and develop life-changing medicines.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.